[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557240":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":39,"locations":48,"responsibleParty":74,"collaborators":76,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":18,"eligibilityCriteria":85,"healthyVolunteers":81,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":18,"studyType":92,"phases":93,"briefSummary":95,"conditions":96,"keywords":100,"overallStatus":51,"whyStopped":18,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Abu Dhabi Health Services Company","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"WGS + Digital Twin Group","EXPERIMENTAL","20 participants who are randomized to have whole-genome sequencing performed on their sample and given access to Predictiv™ Digital Twin. These participants will meet with a genetic counselor for results disclosure and training to access the Predictiv™ Digital Twin platform.",[13],"Genetic: Whole Genome Sequencing",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard of Care Group","NO_INTERVENTION","20 participants who are randomized to not have whole-genome sequencing performed on their sample. These participants will have standard-of-care familial hypercholesterolemia (FH) evaluation using medical history and family history only. They will not receive genetic results or Predictiv™ Digital Twin results as part of this study.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"GENETIC","Whole Genome Sequencing","Participants in this arm will have their blood sample analyzed by whole-genome sequencing (WGS) and will be given access to Predictiv™ Deoxyribonucleic acid (DNA)-based digital twin platform, a web-based interactive application with WGS results. The platform will include positive monogenic and polygenic Familial Hypercholesterolemia results and pharmacogenomics results on statins and clopidogrel. A report of positive monogenic variants will be included in their medical record. This may also include genes on the American College of Medical Genetics and Genomics (ACMG) secondary findings (SF) version 3.2 list if the participant consents to receive these incidental findings. The report will only include pathogenic, likely pathogenic, and variant of uncertain significance (VUS) results.",[9],[26,30,33,36],{"name":27,"affiliation":28,"role":29},"Abdulmajeed BS Alzubaidi, MD","Abu Dhabi Health Services Co. -SEHA","PRINCIPAL_INVESTIGATOR",{"name":31,"affiliation":28,"role":32},"Erik J Koornneef, PHD","STUDY_DIRECTOR",{"name":34,"affiliation":35,"role":32},"Mhy-Lanie Adduru, MD","Predictiv Care, Inc.",{"name":37,"affiliation":28,"role":38},"Salah Eldin HM Hu, MD","STUDY_CHAIR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":18,"email":44},"Alina Naeem, MBBS","CONTACT","+97124102534","alnaeem@seha.ae",{"name":34,"role":42,"phone":46,"phoneExt":18,"email":47},"+14088311991","mhy-lanie@predictivcare.com",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":18,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Abu Dhabi Health Research Center","RECRUITING","Abu Dhabi","Abu Dhabi Emirate","United Arab Emirates","AE",{"type":57,"coordinates":58},"Point",[59,60],54.39696,24.45118,{"lat":60,"lon":59},[63,67,71],{"name":64,"role":42,"phone":65,"phoneExt":18,"email":66},"Salah Eldin HM Hussein, MD","0504485852","sahussein@seha.ae",{"name":68,"role":42,"phone":69,"phoneExt":18,"email":70},"Antoniette C Cano, BSc","0558873919","o-acano@seha.ae",{"name":72,"role":73,"phone":18,"phoneExt":18,"email":18},"Ali H Muwaili, MD","SUB_INVESTIGATOR",{"type":75,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[77],{"name":35,"class":78},"INDUSTRY","100557240","integrating-whole-genome-sequencing-and-digital-twins-into-the-management-of-hypercholesterolemia-in-emiratis-100557240",false,"NCT06535542","Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis","A Randomized Trial of Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis","Inclusion Criteria:\n\n* Patients with 2 or more LDL-C levels greater than 190 mg\u002FdL or 5.0 mmol\u002FL in the past 12 months\n* Undiagnosed patients meeting Possible, Probable or Definitive FH criteria according to Dutch Lipid Clinic Network (DLCN) criteria (Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093\u002Feurheartj\u002Fehr158. Epub 2011 Jun 28.)\n* Patients who have not been on anti-lipidemic medication in the past 3 months\n* Ages 18-55\n* Emirati national\n* All patients must be fluent in English or Arabic\n\nExclusion Criteria:\n\n* \\- Patients who do not meet the above criteria\n* Patients with a previous diagnosis of FH\n* Patients with a progressive debilitating illness\n* Patient with untreated hypothyroidism, history of proteinuria, obstructive liver disease, chronic renal failure, human immunodeficiency virus infection, or on immunosuppressant or steroid or psychiatric medications\n* Patients with untreated clinical anxiety or depression (as measured by a Hospital Anxiety and Depression Scale (HADS) score of ≥ 16 on the depression subscale)\n* Patients who are pregnant","ALL","18 Years","55 Years",{"count":90,"type":91},40,"ESTIMATED","INTERVENTIONAL",[94],"NA","This pilot study investigates integrating whole genome sequencing and digital twin technology for managing hypercholesterolemia in Abu Dhabi clinics. It aims to establish protocols for larger future studies and incorporate genomic insights into routine medical care.",[97,98,99],"Hypercholesterolemia, Autosomal Dominant","Hypercholesterolemia, Autosomal Recessive","Familial Combined Hypercholesterolemia",[101,102,22,103,104,105,106,107,108,109,110,111],"LDH","Familial Hypercholesterolemia","Digital Twins","Management of Hypercholesterolemia","Emirati","Randomized Controlled Trial","Sanger Sequencing","Predictiv Care","Genomic Medicine","Precision Medicine","Pharmacogenomics","2025-03-24",{"date":114,"type":115},"2025-03-25","ACTUAL",{"date":117,"type":115},"2024-07-29",{"date":119,"type":91},"2026-07-15",{"name":5,"class":6},1]